ProQR Therapeutics N.V. General and Administrative Expenses 2011-2026 | PRQR

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses ProQR Therapeutics N.V.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	17.4 M	13.7 M	12.9 M	12.5 M	10.8 M	9.48 M	6.84 M	6.51 M	786 K	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
17.4 M	786 K	10.1 M

Quarterly General and Administrative Expenses ProQR Therapeutics N.V.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	4.91 M	5.32 M	4.59 M	4.12 M	3.34 M	3.51 M	2.81 M	3.45 M	3.92 M	3.92 M	2.9 M	2.88 M	3.19 M	-	2.58 M	2.65 M	-	-	-	2.89 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.32 M	2.58 M	3.56 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	78.3 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	5.41 M	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	116 M	$ 33.23	-4.03 %	$ 584 M	USA
Graybug Vision GRAY	7.89 M	-	-11.23 %	$ 9.65 M	USA
I-Mab IMAB	900 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.4 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	12.7 M	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	7.15 M	-	-13.47 %	$ 169 M	France
Ampio Pharmaceuticals AMPE	7.08 M	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	550 M	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	83.2 M	$ 3.72	-2.75 %	$ 1.11 B	Canada
Athersys ATHX	20.1 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.66 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.95 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	60.8 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	63.3 M	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	531 M	$ 64.66	-1.37 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	7.04 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	99.3 M	$ 8.52	-2.46 %	$ 1.39 B	Britain
Adverum Biotechnologies ADVM	63.1 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	52 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	25.8 M	-	-	-	Russia
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
Certara CERT	85.4 M	$ 7.16	1.49 %	$ 1.15 B	USA
ARCA biopharma ABIO	13.1 M	-	1052.0 %	$ 415 M	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	12.1 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	18 M	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	128 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	89.7 M	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	15.7 M	-	-	$ 231 M	USA
Capricor Therapeutics CAPR	12.8 M	$ 25.91	-3.56 %	$ 694 M	USA
Catalyst Pharmaceuticals CPRX	63.1 M	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	7.17 M	-	4.01 %	$ 150 M	Canada
Codexis CDXS	55.1 M	$ 0.99	-3.28 %	$ 72.7 M	USA
Corvus Pharmaceuticals CRVS	6.88 M	$ 17.75	-0.79 %	$ 852 M	USA
CTI BioPharma Corp. CTIC	84.8 M	-	-	$ 1.2 B	USA
CohBar CWBR	6.45 M	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	5.39 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	5.39 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	136 M	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	100 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	5.92 M	-	5.93 %	$ 314 M	Canada
Denali Therapeutics DNLI	105 M	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	9.33 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	47.9 M	-	-	$ 1.01 B	USA
Eton Pharmaceuticals ETON	18.9 M	$ 17.54	-3.36 %	$ 450 M	USA
Entasis Therapeutics Holdings ETTX	15.2 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	15 M	-	7.55 %	$ 38.1 M	USA